GeoVax prices $3M private placement offering at $1.4799 per unit with warrants

GeoVax Labs, Inc.

Gross proceeds ~$3M; net proceeds ~$2.7M after placement agent fees and expenses.
Issued 2,027,027 pre-funded warrants ($0.0001 exercise) and 4,054,054 common warrants at $1.48 exercise; Series A (5yr), Series B (18mo).
Offering closed May 19, 2026; net proceeds used for working capital and general corporate purposes.
Company agreed to file resale registration statement with SEC for shares underlying the warrants.
A.G.P./Alliance Global Partners acted as sole placement agent; received 7% cash fee plus expense reimbursement.

item 1.01 item 3.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

GeoVax Labs, Inc. entered into Purchase Agreement with the purchasers party thereto (effective 2026-05-18).

Action: entry
Agreement: equity purchase
Counterparty: the purchasers party thereto
Effective: 2026-05-18

Exact text from the filing

On May 18, 2026, GeoVax Labs, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers party thereto, pursuant to which the Company agreed to issue and sell, in an unregistered private placement (the “Offering”), (i) pre-funded warrants

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

GeoVax Labs, Inc. entered into Placement Agency Agreement with A.G.P./Alliance Global Partners (the “Placement Agent”) (effective 2026-05-18).

Action: entry
Agreement: underwriting
Counterparty: A.G.P./Alliance Global Partners (the “Placement Agent”)
Effective: 2026-05-18

Exact text from the filing

A.G.P./Alliance Global Partners (the “Placement Agent”) acted as the exclusive placement agent in connection with the Offering under a Placement Agency Agreement, dated as of May 18, 2026 (the “Placement Agency Agreement”) between the Company and the Placement Agent.

View on SEC.gov

25 material agreements filed in the last 30 days. Browse all material agreements →

GeoVax Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-26-017809

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.